Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M341,901Revenue (TTM) $M72,174Net Margin (%)22.9Altman Z-Score5.1
Enterprise Value $M334,928EPS (TTM) $6.0Operating Margin %29.5Piotroski F-Score6
P/E(ttm)21.3Beneish M-Score-2.5Pre-tax Margin (%)27.8Higher ROA y-yY
Price/Book4.910-y EBITDA Growth Rate %3.9Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %9.1Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow21.6y-y EBITDA Growth Rate %7.2ROA % (ttm)11.8Higher Current Ratio y-yN
Dividend Yield %2.6PEG2.3ROE % (ttm)23.0Less Shares Outstanding y-yY
Payout Ratio %54.0Shares Outstanding M2,694ROIC % (ttm)30.1Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

JNJ is held by these investors:



JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Duato JoaquinExec VP, WW Chair, Pharma 2017-03-03Sell50,000$123.622.67view
Kapusta Ronald AController, CAO 2017-02-28Sell14,543$122.263.81view
Pruden Gary JExec VP, WW Chair, Med Devices 2017-02-28Sell16,299$122.213.85view
Stoffels PaulusExec VP, Chief Scientific Off 2017-02-15Sell22,000$117.298.21view
Ullmann Michael HExec VP, General Counsel 2017-02-01Sell21,735$112.8812.44view
PRINCE CHARLESDirector 2016-10-21Buy875$114.1111.23view
Caruso Dominic JExec VP, Finance; CFO 2016-07-26Sell41,146$125.011.53view
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.011.53view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.039.39view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.799.61view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Multiple-Plaintiff Trial Involving J&J Set to Start May 26 2017 
    Johnson & Johnson to Participate in the Goldman Sachs 38th Annual Global Healthcare Conference May 25 2017 
    Buffett Stocks in Focus: Southwest Airlines May 25 2017 
    The Active Vs. Passive Performance Debate Is Nonsensical May 18 2017 
    S&P 500 and Nasdaq Reach New Highs May 15 2017 
    Johnson & Johnson to Participate in the Jefferies 2017 Global Healthcare Conference May 11 2017 
    Toyota Industries Leads in High-Tech Automotive and Forklifts May 09 2017 
    Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference May 05 2017 
    Johnson & Johnson Introduces Two New Interactive Experiences Showcasing More Than 130 Years Of Healt May 01 2017 
    Microsoft Earnings: Don’t Believe the Disappointment May 01 2017 

    More From Other Websites
    Surprise! The Next Diabetes Breakthrough Could Come From Apple May 28 2017
    Rhode Island's governor uses incentives to lure tech jobs May 28 2017
    3 Dividend Stocks That Thrive in Market Crashes May 27 2017
    Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data May 26 2017
    Multiple-Plaintiff Trial Involving J&J Set to Start May 26 2017
    3 Value Stocks for Every Investor May 26 2017
    Johnson & Johnson : JNJ-US: Dividend Analysis : May 30th, 2017 (record date) : By the numbers : May... May 26 2017
    Johnson & Johnson to Participate in the Goldman Sachs 38th Annual Global Healthcare Conference May 25 2017
    Is Medical Technology Driving the US Healthcare Industry? May 25 2017
    Law: Mayor committed to assisted suicide law despite budget blocks May 25 2017
    Getting Struck Twice: Acquisitions And Spinouts In Biotech May 25 2017
    Kyprolis Could Significantly Drive Amgen’s Revenue Growth in 2017 May 25 2017
    Merck’s Immunology and Cardiovascular Franchise in 1Q17 May 25 2017
    [$$] Planet office: the academics who study the secrets of work May 24 2017
    Drugmaker paying $33M over recalled nonprescription meds May 24 2017
    Johnson & Johnson Settles U.S. Drug Manufacturing Probe May 24 2017
    J&J settles drug manufacturing probe by U.S. states for $33 mln May 24 2017
    Neupogen and Enbrel Could See Falling Revenues in 2017 May 24 2017
    What Do AA+ And AAA Credit Ratings Mean? May 24 2017
    This Dividend Aristocrat is Going to Trade Ex-Dividend on May 25 May 24 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)